login
login

Europe Daily Bulletin No. 13276

21 October 2023
Contents Publication in full By article 22 / 27
ECONOMY - FINANCE - BUSINESS / Competition
European Commission authorises Pfizer’s acquisition of Seagen, a company specialising in antibody-drug conjugates targeting cancers
Brussels, 20/10/2023 (Agence Europe)

On Thursday 19 October, the European Commission announced its unconditional approval of the acquisition of the US biotechnology company Seagen, which develops and markets targeted cancer therapies known as “antibody-drug conjugates”, by the US pharmaceutical company Pfizer. By acquiring sole control of Seagen through a share purchase, Pfizer aims to diversify its portfolio and strengthen its innovative medicines development business.

The transaction was notified to the Commission on...

Contents

EXTERNAL ACTION
Russian invasion of Ukraine
SECTORAL POLICIES
INSTITUTIONAL
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
ECONOMY - FINANCE - BUSINESS
COUNCIL OF EUROPE
NEWS BRIEFS
CORRIGENDUM